Hims & Hers has entered Australia in its first Asia-Pacific expansion, offering branded GLP-1 weight-loss drugs and other treatments to men through Pilot, the Sydney-based men’s telehealth brand acquired with digital health platform Eucalyptus earlier this year. Hims plans to transition existing Pilot clinicians to its platform and launch Juniper, Eucalyptus’s women’s health brand, in Australia later this year. The expansion is intended to improve access to preventative and weight-loss care, particularly for rural customers, while combining services previously bought separately. Hims is targeting $6.5 billion in revenue by 2030; international expansion has increased subscriptions and monthly revenue per subscriber by 21% from a year earlier but reduced gross profit margins, which the company expects to remain below historical levels as overseas offerings accelerate.